Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.8K

Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression

Sonia Liberati, Maria B Morelli, Consuelo Amantini

  • 1School of Pharmacy, Experimental Medicine Section, University of Camerino, Via Madonna delle Carceri 9, 62032, Camerino (MC), Italy. giorgio.santoni@unicam.it.

Current Protein & Peptide Science
|July 9, 2014
PubMed

Insights

The transient receptor potential vanilloid 2 (TRPV2) channel plays a dual role in cancer. While its activation can inhibit proliferation, its altered expression and function are linked to increased tumor malignancy and invasiveness.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Physiology

Background:

  • Transient Receptor Potential Vanilloid 2 (TRPV2) is a channel protein involved in cellular processes.
  • Physiological TRPV2 activation typically inhibits cell proliferation and induces apoptosis.
  • Alterations in TRPV2 signaling are implicated in various pathologies, including cancer.

Purpose of the Study:

  • To review the role of the TRPV2 channel in tumor progression.
  • To understand how TRPV2 dysfunction contributes to cancer development and metastasis.
  • To explore the impact of TRPV2 variants on cancer cell behavior.

Main Methods:

  • Literature review of studies investigating TRPV2 in cancer.
  • Analysis of TRPV2 expression patterns in different tumor types.
  • Examination of functional consequences of TRPV2 alterations on cancer cell proliferation, apoptosis, and invasiveness.

Main Results:

  • Loss or alteration of TRPV2 signaling promotes uncontrolled cell proliferation and resistance to apoptosis.
  • In prostate cancer, TRPV2 activation can enhance invasiveness, with higher expression in metastatic and castration-resistant cells.
  • Reduced expression of a TRPV2 variant is observed in bladder cancer, correlating with increased malignancy.
  • Elevated TRPV2 expression is associated with advanced stages and metastasis in esophageal squamous cell carcinoma.

Conclusions:

  • TRPV2 plays a significant role in tumor progression, with its dysregulation contributing to increased cancer malignancy and invasiveness.
  • Altered expression and functional variants of TRPV2 are critical factors in the development and spread of various cancers.
  • Targeting TRPV2 pathways may offer potential therapeutic strategies for cancer treatment.

More Related Videos

Three-Dimensional 3D Tumor Spheroid Invasion Assay12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

59.4K
Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV412:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.6K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K